TGFB1 and COVID-19: That is, the downregulation of TGF-β or reduction of Treg cells may lead to pathological inflammation caused by aberrant T-cell response, which conforms to the fact that decreased responses of Treg cells in COVID-19 intensive care unit (ICU) patients is strongly related to hyperinflammation and disease pathogenesis (14).